ArticleEuropean journal of clinical pharmacology2021

Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19.

Chia Siang Kow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.